Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial-Reference-Cited by-同舟云学术

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

Published:2017 Issue:3 Volume:15 Page:395
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Inoue Nagamu¹,Kobayashi Kiyonori²,Naganuma Makoto³,Hirai Fumihito⁴,Ozawa Morio⁵,Arikan Dilek⁶,Huang Bidan⁶,Robinson Anne M.⁶,Thakkar Roopal B.⁶,Hibi Toshifumi⁷

Affiliation:

1. Center for Preventive Medicine, Keio University Hospital, Tokyo, Japan.

2. Department of Gastroenterology, Kitasato University Hospital, Kanagawa, Japan.

3. Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Fukuoka, Japan.

4. IBD Center, Fukuoka University Chikushi Hospital, Fukuoka, Japan.

5. AbbVie GK, Tokyo, Japan.

6. AbbVie Inc., North Chicago, IL, USA.

7. Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.

Funder

AbbVie GK

Eisai Co., Ltd.

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

https://synapse.koreamed.org/pdf/10.5217/ir.2017.15.3.395

Reference14 articles.

1. Behçet's Disease

2. Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease

3. The diagnostic criteria for Behçet's disease (2003). Ministry of Health, Labour and Welfare Web site. Accessed April 4, 2017. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000089968.pdf

4. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease

5. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea;BMC Gastroenterology;2023-12-19

2. Treatment Options in Pediatric Behçet’s Disease;Pediatric Drugs;2023-01-10

3. Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN);Gut and Liver;2022-12-29

4. Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab;DEN Open;2022-12-15

5. Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus;Modern Rheumatology Case Reports;2022-10-07